Alcohol consumption and risk of inflammatory bowel disease among three prospective US cohorts

Kevin Casey, Emily W Lopes, Blake Niccum, Kristin Burke, Ashwin N Ananthakrishnan, Paul Lochhead , James M Richter, Andrew T Chan, Hamed Khalili

Published in Alimentary Pharmacology and Therapeutics, January 2022

Incidence, outcomes, and impact of COVID-19 on inflammatory bowel disease: propensity matched research network analysis

Yousaf Hadi, Parambir S Dulai, Justin Kupec, Nabeeha Mohy-Ud-Din, Vipul Jairath, Francis A Farraye, Gursimran S Kochhar

Published in Alimentary Pharmacology and Therapeutics, January 2022

First-line treatment with infliximab versus conventional treatment in children with newly diagnosed moderate-to-severe Crohn’s disease: an open-label multicentre randomised controlled trial

Maria M E Jongsma, Martine A Aardoom, Martinus A Cozijnsen, Merel van Pieterson, Tim de Meij, Michael Groeneweg, Obbe F Norbruis, Victorien M Wolters, Herbert M van Wering, Iva Hojsak, Kaija-Leena Kolho, Thalia Hummel, Janneke Stapelbroek, Cathelijne van der Feen, Patrick F van Rheenen, Michiel P van Wijk, Sarah T A Teklenburg-Roord, Marco W J Schreurs, Dimitris Rizopoulos, Michail Doukas, Johanna C Escher, Janneke N Samsom, Lissy de Ridder

Published in Gut 2022

Disease Prognostic Biomarkers in Inflammatory Bowel Diseases—A Reality Check

Matthias Zilbauer, Robert Heuschkel

Published in Journal of Crohn's and Colitis, January 2022

Accuracy of Gastrointestinal Ultrasound and Calprotectin in the Assessment of Inflammation and its Location in Patients with an Ileoanal Pouch

Zaid S Ardalan, Antony B Friedman, Danny Con, Sujievvan Chandran, David Gibson, Alan Pham, Peter De Cruz, Kwang Tay, Stephen Bell, Ourania Rosella, Miles P Sparrow, Peter R Gibson

Published in Journal of Crohn's and Colitis

SAFETY AND EFFECTIVENESS OF THE BNT162B2 MRNA COVID-19 VACCINE IN A NATIONWIDE COHORT OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Muhammad Khan,Kamran Mushtaq,Muhammad Saddique,Mohd Alghizzawi,Muhammad Yasir,Hafiz Younis,Farah Rashid,Deema AlSoub,Rafie Yakoob,Saad AlKaabi,Khalid Al-Ejji

Published in Gastroenterology,  February 2022

Immunomodulator withdrawal from anti-TNF therapy is not associated with loss of response in inflammatory bowel disease

R. Mahmoud,J.P.D. Schultheiss,J.M. Louwers,M.T. van der Kaaij,B.P. van Hellemondt,N. Mahmmod,P.G. van Boeckel,B. Jharap,H.H. Fidder,B. Oldenburg

Published in Clinical Gastroenterology and Hepatology

Twenty-first Century Trends in the Global Epidemiology of Pediatric-Onset Inflammatory Bowel Disease: Systematic Review

M. Ellen Kuenzig,Stephen G. Fung,Luba Marderfeld,Joyce W.Y. Mak,Gilaad G. Kaplan,Siew C. Ng,David C. Wilson,Fiona Cameron,Paul Henderson,Paulo G. Kotze,Jasmine Bhatti,Vixey Fang,Samantha Gerber,Evelyne Guay,Supun Kotteduwa Jayawarden,Leo Kadota,D. Fernando,Maldonado,Jessica Amankwah Osei,Ryan Sandarage,Amanda Stanton,Melissa Wan

Published in Gastroenterology, Jan 2022

The Crohn's disease exclusion diet for induction and maintenance of remission in adults with mild-to-moderate Crohn's disease (CDED-AD): an open-label, pilot, randomised trial

Yanai H, Levine A, Hirsch A, Boneh RS, Kopylov U, Eran HB, Cohen NA, Ron Y, Goren I, Leibovitzh H, Wardi J, Zittan E, Ziv-Baran T, Abramas L, Fliss-Isakov N, Raykhel B, Gik TP, Dotan I, Maharshak N. 

Published in Lancet Gastroenterol Hepatol. 2022 Jan

Effects of vitamin D supplementation on blood markers in ulcerative colitis patients: a systematic review and meta-analysis.

Guan Y, Hao Y, Guan Y, Bu H, Wang H.

Published in:Eur J Nutr. 2022 Feb